Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3706 AL 3720

Angiotensin-converting enzyme insertion/deletion polymorphism and the longitudinal progression of Alzheimer's disease

Chou PS, Wu MN, Chou MC, Chien I, Yang YH.

Geriatr Gerontol Int. 2017 Oct;17(10):1544-1550. doi: 10.1111/ggi.12929. Epub 2016 Nov 10.

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

Knapp M, Chua KC, Broadbent M, Chang CK, Fernandez JL, Milea D, Romeo R, Lovestone S, Spencer M, Thompson G, Stewart R, Hayes RD.

BMJ Open. 2016 Nov 18;6(11):e013591. doi: 10.1136/bmjopen-2016-013591.

Visual system manifestations of Alzheimer's disease

Kusne Y, Wolf AB, Townley K, Conway M, Peyman GA.

Acta Ophthalmol. 2017 Dec;95(8):e668-e676. doi: 10.1111/aos.13319. Epub 2016 Nov 19.

Molecular imaging in the diagnosis of Alzheimer's disease and related disorders

Koric L, Guedj E, Habert MO, Semah F, Branger P, Payoux P, Le Jeune F; CMMR study group.

Rev Neurol (Paris). 2016 Dec;172(12):725-734. doi: 10.1016/j.neurol.2016.10.009. Epub 2016 Nov 17.

Geroscience: Addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis

Martin GM.

Exp Gerontol. 2017 Aug;94:46-51. doi: 10.1016/j.exger.2016.11.008. Epub 2016 Nov 19.

[Effectiveness of non-pharmacological interventions in the quality of life of caregivers of Alzheimer]

Amador-Marín B, Guerra-Martín MD.

Gac Sanit. 2017 Mar-Apr;31(2):154-160. doi: 10.1016/j.gaceta.2016.09.006. Epub 2016 Nov 22.

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2016 Nov 25;16(1):195. doi: 10.1186/s12877-016-0371-6.

Emotional quotient in frontotemporal dementia vs. Alzheimer's disease: the role of socioemotional agnosia

Carr AR, Samimi MS, Paholpak P, Jimenez EE, Mendez MF.

Cogn Neuropsychiatry. 2017 Jan;22(1):28-38. doi: 10.1080/13546805.2016.1259612. Epub 2016 Nov 30.

Alzheimer's disease: expedition into the unknown

The Lancet.

Lancet. 2016 Dec 3;388(10061):2713. doi: 10.1016/S0140-6736(16)32457-6. Epub 2016 Dec 2.

Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia

Kim J, Cho SG, Song M, Kang SR, Kwon SY, Choi KH, Choi SM, Kim BC, Song HC.

Medicine (Baltimore). 2016 Dec;95(49):e5622. doi: 10.1097/MD.0000000000005622.

Effect of galantamine on attention in patients with Alzheimer's disease combined with cerebrovascular disease

Park JJ, Choi SH, Kim S, Lee AY, Moon SY, Lee JH, Kwon JC, Park KW, Ku BD, Han HJ, Kim EJ, Shim YS.

Geriatr Gerontol Int. 2017 Oct;17(10):1661-1666. doi: 10.1111/ggi.12934. Epub 2016 Dec 9.

African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation

Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.

Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.

Molecular Diagnostics of Ageing and Tackling Age-related Disease

Timmons JA.

Trends Pharmacol Sci. 2017 Jan;38(1):67-80. doi: 10.1016/j.tips.2016.11.005. Epub 2016 Dec 12.

[Non-pharmacological treatment of dementia in geriatric psychiatry care units : Scoping review]

Göhner A, Hüll M, Voigt-Radloff S.

Z Gerontol Geriatr. 2018 Feb;51(2):169-183. doi: 10.1007/s00391-016-1161-7. Epub 2016 Dec 16.

Special Issue: "Molecules against Alzheimer"

Decker M, Muñoz-Torrero D.

Molecules. 2016 Dec 16;21(12):1736. doi: 10.3390/molecules21121736.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias